MeSH D049268 - positron-emission tomography
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014055:Emission-computed tomography
0 Companies
0 Drugs
Success rate
D049268:
Positron-emission tomography
D000072078:Positron emission tomography computed tomography
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Advanced Accelerator Applications | Gallium | Netspot | 2032-08-10 | 2016-06-01 | ||
| Curium | Gallium | Gallium Ga | 1982-01-01 | |||
| GE Healthcare | Gallium | Gallium Ga | 1982-01-01 | |||
| Gallium | Neoscan | 1982-01-01 | ||||
| Genta | Gallium | Ganite | 1991-01-17 | |||
| Lantheus Medical Imaging | Gallium | Gallium Ga | 1982-01-01 | |||
| Novartis | Gozetotide, Gallium | Locametz | 2022-12-09 | |||
| Telix | Gallium | Illuccix | 2035-07-28 | 2021-12-17 | ||
| UCLA | Gallium | Gallium Ga 68 Gozetotide | 2020-12-01 | |||
| UCSF | Gallium | Gallium Ga 68 Gozetotide | 2020-12-01 | |||
| University of Iowa | Gallium | Gallium Ga 68 Edotreotide | 2019-08-21 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
50%1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use